Masud Shah Hashmi, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 E Pottawatamie St, Tecumseh, MI 49286 Phone: 517-424-3050 Fax: 517-424-3613 |
Laurie A Barkway, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6869 S Occidental Rd, Tecumseh, MI 49286 Phone: 517-423-4777 Fax: 517-423-7257 |
Jayesh R Shah, MD Emergency Medicine - Emergency Medical Services Medicare: Medicare Enrolled Practice Location: 500 E Pottawatamie St, Tecumseh, MI 49286 Phone: 517-423-2141 |
Michael E Washburn, MD Emergency Medicine - Emergency Medical Services Medicare: Not Enrolled in Medicare Practice Location: 500 E Pottawatamie St, Tecumseh, MI 49286 Phone: 517-423-2141 |
Eric P Smith, DO Emergency Medicine - Emergency Medical Services Medicare: Accepting Medicare Assignments Practice Location: 500 E Pottawatamie St, Tecumseh, MI 49286 Phone: 517-423-2141 |
News Archive
In a study published online by JAMA Otolaryngology-Head & Neck Surgery, Kathleen M. Schieffer, B.S., of the Pennsylvania State University College of Medicine, Hershey, Pa., and colleagues examined the association between sensorineural hearing loss and conductive hearing loss and iron deficiency anemia in adults ages 21 to 90 years in the United States.
Early evidence suggests that gene therapy developed at St. Jude Children's Research Hospital will lead to broad protection for infants with the devastating immune disorder X-linked severe combined immunodeficiency disorder.
The American College of Rheumatology (ACR) released its 2015 Guideline for the Treatment of Rheumatoid Arthritis (RA) during the 2015 ACR/ARHP Annual Meeting in San Francisco.
The National Institutes of Health has launched a centralized, secure enclave to store and study vast amounts of medical record data from people diagnosed with coronavirus disease across the country.
Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. today announced the companies have begun enrolling patients in an international Phase 3 trial to evaluate Nexavar® (sorafenib) tablets for the treatment of patients with radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer.
› Verified 2 days ago